Search | VHL Search Portal

1.

Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma.

Bishop, Michael R; Dickinson, Michael; Purtill, Duncan; Barba, Pere; Santoro, Armando; Hamad, Nada; Kato, Koji; Sureda, Anna; Greil, Richard; Thieblemont, Catherine; Morschhauser, Franck; Janz, Martin; Flinn, Ian; Rabitsch, Werner; Kwong, Yok-Lam; Kersten, Marie J; Minnema, Monique C; Holte, Harald; Chan, Esther H L; Martinez-Lopez, Joaquin; Müller, Antonia M S; Maziarz, Richard T; McGuirk, Joseph P; Bachy, Emmanuel; Le Gouill, Steven; Dreyling, Martin; Harigae, Hideo; Bond, David; Andreadis, Charalambos; McSweeney, Peter; Kharfan-Dabaja, Mohamed; Newsome, Simon; Degtyarev, Evgeny; Awasthi, Rakesh; Del Corral, Christopher; Andreola, Giovanna; Masood, Aisha; Schuster, Stephen J; Jäger, Ulrich; Borchmann, Peter; Westin, Jason R.

N Engl J Med ; 386(7): 629-639, 2022 02 17.

Article in English | MEDLINE | ID: mdl-34904798

2.

Expedited evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantation.

Roloff, Gregory W; Kosuri, Satyajit; Nawas, Mariam T; DuVall, Adam S; Patel, Anand A; Riedell, Peter A; Odenike, Olatoyosi; Stock, Wendy; Larson, Richard A; Bishop, Michael R; Nunley, Emma; Godley, Lucy A; Hathaway, Feighanne; Del Gaudio, Daniela; Das, Soma; Canham, Lorraine E; Drazer, Michael W.

Haematologica ; 2024 Apr 11.

Article in English | MEDLINE | ID: mdl-38618681

3.

KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results.

Shah, Bijal D; Bishop, Michael R; Oluwole, Olalekan O; Logan, Aaron C; Baer, Maria R; Donnellan, William B; O'Dwyer, Kristen M; Holmes, Houston; Arellano, Martha L; Ghobadi, Armin; Pagel, John M; Lin, Yi; Cassaday, Ryan D; Park, Jae H; Abedi, Mehrdad; Castro, Januario E; DeAngelo, Daniel J; Malone, Adriana K; Mawad, Raya; Schiller, Gary J; Rossi, John M; Bot, Adrian; Shen, Tong; Goyal, Lovely; Jain, Rajul K; Vezan, Remus; Wierda, William G.

Blood ; 138(1): 11-22, 2021 07 08.

Article in English | MEDLINE | ID: mdl-33827116

4.

KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study.

Shah, Bijal D; Ghobadi, Armin; Oluwole, Olalekan O; Logan, Aaron C; Boissel, Nicolas; Cassaday, Ryan D; Leguay, Thibaut; Bishop, Michael R; Topp, Max S; Tzachanis, Dimitrios; O'Dwyer, Kristen M; Arellano, Martha L; Lin, Yi; Baer, Maria R; Schiller, Gary J; Park, Jae H; Subklewe, Marion; Abedi, Mehrdad; Minnema, Monique C; Wierda, William G; DeAngelo, Daniel J; Stiff, Patrick; Jeyakumar, Deepa; Feng, Chaoling; Dong, Jinghui; Shen, Tong; Milletti, Francesca; Rossi, John M; Vezan, Remus; Masouleh, Behzad Kharabi; Houot, Roch.

Lancet ; 398(10299): 491-502, 2021 08 07.

Article in English | MEDLINE | ID: mdl-34097852

5.

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Schuster, Stephen J; Bishop, Michael R; Tam, Constantine S; Waller, Edmund K; Borchmann, Peter; McGuirk, Joseph P; Jäger, Ulrich; Jaglowski, Samantha; Andreadis, Charalambos; Westin, Jason R; Fleury, Isabelle; Bachanova, Veronika; Foley, S Ronan; Ho, P Joy; Mielke, Stephan; Magenau, John M; Holte, Harald; Pantano, Serafino; Pacaud, Lida B; Awasthi, Rakesh; Chu, Jufen; Anak, Özlem; Salles, Gilles; Maziarz, Richard T.

N Engl J Med ; 380(1): 45-56, 2019 01 03.

Article in English | MEDLINE | ID: mdl-30501490

6.

Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.

Schuster, Stephen J; Tam, Constantine S; Borchmann, Peter; Worel, Nina; McGuirk, Joseph P; Holte, Harald; Waller, Edmund K; Jaglowski, Samantha; Bishop, Michael R; Damon, Lloyd E; Foley, Stephen Ronan; Westin, Jason R; Fleury, Isabelle; Ho, P Joy; Mielke, Stephan; Teshima, Takanori; Janakiram, Murali; Hsu, Jing-Mei; Izutsu, Koji; Kersten, Marie José; Ghosh, Monalisa; Wagner-Johnston, Nina; Kato, Koji; Corradini, Paolo; Martinez-Prieto, Marcela; Han, Xia; Tiwari, Ranjan; Salles, Gilles; Maziarz, Richard T.

Lancet Oncol ; 22(10): 1403-1415, 2021 10.

Article in English | MEDLINE | ID: mdl-34516954

7.

Current Status of CAR T Cell Therapy for Leukemias.

Harris, Katherine; LaBelle, James L; Bishop, Michael R.

Curr Treat Options Oncol ; 22(7): 62, 2021 06 07.

Article in English | MEDLINE | ID: mdl-34097135

8.

Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic.

Bachanova, Veronika; Bishop, Michael R; Dahi, Parastoo; Dholaria, Bhagirathbhai; Grupp, Stephan A; Hayes-Lattin, Brandon; Janakiram, Murali; Maziarz, Richard T; McGuirk, Joseph P; Nastoupil, Loretta J; Oluwole, Olalekan O; Perales, Miguel-Angel; Porter, David L; Riedell, Peter A.

Biol Blood Marrow Transplant ; 26(7): 1239-1246, 2020 07.

Article in English | MEDLINE | ID: mdl-32298807

9.

Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2.

Godfrey, James K; Nabhan, Chadi; Karrison, Theodore; Kline, Justin P; Cohen, Kenneth S; Bishop, Michael R; Stadler, Walter M; Karmali, Reem; Venugopal, Parameswaran; Rapoport, Aaron P; Smith, Sonali M.

Cancer ; 125(11): 1830-1836, 2019 06 01.

Article in English | MEDLINE | ID: mdl-30707764

10.

New hope to prevent ALL relapse after transplant.

Bishop, Michael R.

Blood ; 139(17): 2580-2581, 2022 04 28.

Article in English | MEDLINE | ID: mdl-35482346

11.

Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia.

Hsu, Jingmei; Artz, Andrew; Mayer, Sebastian A; Guarner, Danielle; Bishop, Michael R; Reich-Slotky, Ronit; Smith, Sonali M; Greenberg, June; Kline, Justin; Ferrante, Rosanna; Phillips, Adrienne A; Gergis, Usama; Liu, Hongtao; Stock, Wendy; Cushing, Melissa; Shore, Tsiporah B; van Besien, Koen.

Biol Blood Marrow Transplant ; 24(2): 359-365, 2018 02.

Article in English | MEDLINE | ID: mdl-29128555

12.

Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma.

Trujillo, Jonathan A; Godfrey, James; Hu, Yifei; Huang, Jun; Smith, Sonali M; Frigault, Matthew J; DeFilipp, Zachariah; Appelbaum, Daniel; Pu, Yonglin; Feinberg, Nicholas; Althaus, Thomas; Bishop, Michael R; Riedell, Peter A; Kline, Justin.

Blood ; 137(24): 3454-3459, 2021 06 17.

Article in English | MEDLINE | ID: mdl-33881502

13.

The benefit of CAR T cells in older patients.

Bishop, Michael R.

Blood ; 135(23): 2020-2021, 2020 06 04.

Article in English | MEDLINE | ID: mdl-32497222

14.

Mature T- and NK-cell non-Hodgkin lymphoma in children and young adolescents.

Pillai, Vinodh; Tallarico, Michael; Bishop, Michael R; Lim, Megan S.

Br J Haematol ; 173(4): 573-81, 2016 05.

Article in English | MEDLINE | ID: mdl-26992145

15.

The case for CAR T-cell therapy in follicular lymphomas.

Bishop, Michael R.

Blood ; 134(7): 577-578, 2019 08 15.

Article in English | MEDLINE | ID: mdl-31416814

16.

Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation.

Fowler, Daniel H; Mossoba, Miriam E; Steinberg, Seth M; Halverson, David C; Stroncek, David; Khuu, Hahn M; Hakim, Frances T; Castiello, Luciano; Sabatino, Marianna; Leitman, Susan F; Mariotti, Jacopo; Gea-Banacloche, Juan C; Sportes, Claude; Hardy, Nancy M; Hickstein, Dennis D; Pavletic, Steven Z; Rowley, Scott; Goy, Andre; Donato, Michele; Korngold, Robert; Pecora, Andrew; Levine, Bruce L; June, Carl H; Gress, Ronald E; Bishop, Michael R.

Blood ; 121(15): 2864-74, 2013 Apr 11.

Article in English | MEDLINE | ID: mdl-23426943

17.

Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.

Kochenderfer, James N; Dudley, Mark E; Carpenter, Robert O; Kassim, Sadik H; Rose, Jeremy J; Telford, William G; Hakim, Frances T; Halverson, David C; Fowler, Daniel H; Hardy, Nancy M; Mato, Anthony R; Hickstein, Dennis D; Gea-Banacloche, Juan C; Pavletic, Steven Z; Sportes, Claude; Maric, Irina; Feldman, Steven A; Hansen, Brenna G; Wilder, Jennifer S; Blacklock-Schuver, Bazetta; Jena, Bipulendu; Bishop, Michael R; Gress, Ronald E; Rosenberg, Steven A.

Blood ; 122(25): 4129-39, 2013 Dec 12.

Article in English | MEDLINE | ID: mdl-24055823

18.

Optimizing Administration of CAR T-Cell Therapy During the COVID-19 Pandemic.

Bishop, Michael R.

Clin Adv Hematol Oncol ; 18(7): 400-403, 2020 07.

Article in English | MEDLINE | ID: mdl-32903251

19.

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transplantation.

de Lima, Marcos; Porter, David L; Battiwalla, Minoo; Bishop, Michael R; Giralt, Sergio A; Hardy, Nancy M; Kröger, Nicolaus; Wayne, Alan S; Schmid, Christoph.

Biol Blood Marrow Transplant ; 20(1): 4-13, 2014 Jan.

Article in English | MEDLINE | ID: mdl-24018392

20.

Symptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors.

Bevans, Margaret F; Mitchell, Sandra A; Barrett, John A; Bishop, Michael R; Childs, Richard; Fowler, Daniel; Krumlauf, Michael; Prince, Patricia; Shelburne, Nonniekaye; Wehrlen, Leslie; Yang, Li.

Biol Blood Marrow Transplant ; 20(3): 387-95, 2014 Mar.

Article in English | MEDLINE | ID: mdl-24355521

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export:

Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma.

Expedited evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantation.

KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results.

KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study.

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.

Current Status of CAR T Cell Therapy for Leukemias.

Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic.

Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2.

New hope to prevent ALL relapse after transplant.

Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia.

Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma.

The benefit of CAR T cells in older patients.

Mature T- and NK-cell non-Hodgkin lymphoma in children and young adolescents.

The case for CAR T-cell therapy in follicular lymphomas.

Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation.

Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.

Optimizing Administration of CAR T-Cell Therapy During the COVID-19 Pandemic.

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transplantation.

Symptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors.